SE506179C2 - Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum - Google Patents
Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikumInfo
- Publication number
- SE506179C2 SE506179C2 SE9000050A SE9000050A SE506179C2 SE 506179 C2 SE506179 C2 SE 506179C2 SE 9000050 A SE9000050 A SE 9000050A SE 9000050 A SE9000050 A SE 9000050A SE 506179 C2 SE506179 C2 SE 506179C2
- Authority
- SE
- Sweden
- Prior art keywords
- benazepril
- hydrochlorothiazide
- thiazide diuretic
- dose
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30038389A | 1989-01-23 | 1989-01-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9000050L SE9000050L (sv) | 1990-07-24 |
SE506179C2 true SE506179C2 (sv) | 1997-11-17 |
Family
ID=23158879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9000050A SE506179C2 (sv) | 1989-01-23 | 1990-01-08 | Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum |
Country Status (24)
Country | Link |
---|---|
JP (1) | JP3009694B2 (xx) |
KR (1) | KR0141479B1 (xx) |
AT (1) | AT401728B (xx) |
AU (1) | AU629288B2 (xx) |
BE (1) | BE1002736A4 (xx) |
CA (1) | CA2008126C (xx) |
CH (1) | CH680568A5 (xx) |
CY (1) | CY1835A (xx) |
DE (2) | DE4001496C2 (xx) |
DK (1) | DK175204B1 (xx) |
FR (1) | FR2641971B1 (xx) |
GB (1) | GB2227172B (xx) |
HK (1) | HK98995A (xx) |
IE (1) | IE61784B1 (xx) |
IL (1) | IL93117A0 (xx) |
IT (1) | IT1239744B (xx) |
LU (1) | LU87660A1 (xx) |
MX (1) | MX9203362A (xx) |
NL (1) | NL194958C (xx) |
NZ (1) | NZ232182A (xx) |
SA (1) | SA90100151B1 (xx) |
SE (1) | SE506179C2 (xx) |
SG (1) | SG176194G (xx) |
ZA (1) | ZA90429B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100221695B1 (ko) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | 약학적 구상 제형 |
DK9200258U4 (da) * | 1992-03-11 | 1993-07-23 | Merck & Co Inc | Farmaceutisk præparat indeholdende enalapril til brug mod hypertension |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
CN102579346B (zh) * | 2012-03-02 | 2013-09-25 | 海南美兰史克制药有限公司 | 贝那普利/氢氯噻嗪药物组合物脂质体固体制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4217347A (en) * | 1977-12-27 | 1980-08-12 | E. R. Squibb & Sons, Inc. | Method of treating hypertension and medicaments therefor |
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
US4410520A (en) * | 1981-11-09 | 1983-10-18 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
ZA833903B (en) * | 1982-06-01 | 1984-11-28 | Merck & Co Inc | Benzofused lactams as antihypertensives |
US4520021A (en) * | 1982-07-02 | 1985-05-28 | Merck & Co., Inc. | Substituted caprolactam derivatives as antihypertensives |
-
1990
- 1990-01-08 SE SE9000050A patent/SE506179C2/sv not_active IP Right Cessation
- 1990-01-15 CH CH112/90A patent/CH680568A5/de not_active IP Right Cessation
- 1990-01-17 GB GB9001054A patent/GB2227172B/en not_active Expired - Lifetime
- 1990-01-18 LU LU87660A patent/LU87660A1/de unknown
- 1990-01-19 DE DE4001496A patent/DE4001496C2/de not_active Expired - Lifetime
- 1990-01-19 NZ NZ232182A patent/NZ232182A/en unknown
- 1990-01-19 IT IT47548A patent/IT1239744B/it active IP Right Grant
- 1990-01-19 CA CA002008126A patent/CA2008126C/en not_active Expired - Lifetime
- 1990-01-19 FR FR909000612A patent/FR2641971B1/fr not_active Expired - Lifetime
- 1990-01-19 DE DE2001199041 patent/DE10199041I1/de active Pending
- 1990-01-22 AT AT0013590A patent/AT401728B/de not_active IP Right Cessation
- 1990-01-22 ZA ZA90429A patent/ZA90429B/xx unknown
- 1990-01-22 NL NL9000158A patent/NL194958C/nl not_active IP Right Cessation
- 1990-01-22 KR KR1019900000697A patent/KR0141479B1/ko not_active IP Right Cessation
- 1990-01-22 BE BE9000074A patent/BE1002736A4/fr not_active IP Right Cessation
- 1990-01-22 IE IE23390A patent/IE61784B1/en not_active IP Right Cessation
- 1990-01-22 JP JP2010782A patent/JP3009694B2/ja not_active Expired - Lifetime
- 1990-01-22 AU AU48703/90A patent/AU629288B2/en not_active Expired
- 1990-01-22 DK DK199000174A patent/DK175204B1/da not_active IP Right Cessation
- 1990-01-22 IL IL93117A patent/IL93117A0/xx not_active IP Right Cessation
- 1990-04-04 SA SA90100151A patent/SA90100151B1/ar unknown
-
1992
- 1992-06-25 MX MX9203362A patent/MX9203362A/es unknown
-
1994
- 1994-12-16 SG SG176194A patent/SG176194G/en unknown
-
1995
- 1995-06-22 HK HK98995A patent/HK98995A/xx not_active IP Right Cessation
- 1995-12-01 CY CY183595A patent/CY1835A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4248857A (en) | Sustained release pharmaceutical compositions | |
CA1147651A (en) | Sustained release pharmaceutical compositions | |
AU613663B2 (en) | Sustained release etodolac | |
EP1239831B1 (en) | Improved pharmaceutical compositions for poorly soluble drugs | |
DE69732113T2 (de) | Schnelllösliche tablette enthaltend galanthaminhydrobromid | |
CA1294877C (en) | Anti-inflammatory cream composition | |
PL172571B1 (pl) | Doustny preparat morfiny PL PL PL | |
US4217347A (en) | Method of treating hypertension and medicaments therefor | |
JP2003300907A (ja) | 抗真菌製剤、及びその製造方法ならびに使用 | |
SE506179C2 (sv) | Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum | |
US5853756A (en) | Controlled release formulations of Ranitidine | |
JPH0840906A (ja) | 過血糖症を治療するための薬剤学的製剤 | |
AU776242B2 (en) | Riluzole and alpha-tocopherol combination | |
SE465751B (sv) | Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist | |
US4804540A (en) | Process for preparing the combination products of triamterene and hydrochlorothiazide | |
KR960009649B1 (ko) | 알도오스 환원효소 저해작용을 갖고 또한 흡수성이 양호한 약제 조성물 | |
JPS61165327A (ja) | 肝疾患治療薬 | |
JPH05170741A (ja) | トロンボキサンa▲2▼拮抗剤 | |
JPH03275624A (ja) | 新規な皮膚潰瘍治療剤 | |
JPH03135917A (ja) | 尿酸排泄剤 | |
WO2001003701A1 (en) | An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease | |
WO2001003703A1 (en) | An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease | |
CA2361581A1 (en) | Method for the prevention or reduction of cariovascular events associated with coronary intervention | |
DE2456172A1 (de) | Calciumhaltiges arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |